CASC19 and neoplasm: Using RNA-Seq, RT-qPCR, bioinformatics, and murine tumor xenograft models, one group reported that the expression of five lincRNAs, including LINC00973, LINC00941, CASC19, CCAT1 and BCAR4, are consistently altered in HT-29 and HCT-116 cells after treatments with 5-FU, oxaliplatin and irinotecan both in vitro and in vivo.